Table 1a. Socio-demographic and Clinical Parameters of Included Patients at Baseline.
| Parameter | No. (%) |
|---|---|
| Purpose of Study (n = 33) | |
| Assess Quality of Life | 13 (39.4%) |
| Establish Reliability of External Assessment Tool | 10 (30.3%) |
| Determine Determinants of Quality of Life | 7 (21.2%) |
| Establish Reliability of the FACT-G | 3 (9.1%) |
| Primary Cancer (n = 33) | |
| Heterogeneous | 12 (36.4%) |
| Lung | 7 (21.2%) |
| Head and Neck | 4 (12.1%) |
| Prostate | 2 (6.1%) |
| Breast | 2 (6.1%) |
| Other | 6 (18.2%) |
| Country of Study (n = 32) | |
| United States | 17 (51.5%) |
| Canada | 3 (9.1%) |
| Japan | 3 (9.1%) |
| China | 3 (9.1%) |
| Australia | 1 (3.0%) |
| India | 1 (3.0%) |
| Philippines | 1 (3.0%) |
| South Korea | 1 (3.0%) |
| Sweden | 1 (3.0%) |
| Uruguay | 1 (3.0%) |